Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

Clinical trial NCT02840487 · COMPLETED

Trial details

NCT number: NCT02840487
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Zika Infection Zika-Specific Immune Response

Start date: 2016-08-02
Primary completion: 2019-03-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.